- Open
- 0.85
- High
- 0.90
- Low
- 0.80
- Close
- 0.84
- Change
- -0.05 (-5.88%)
- Volume
- 1,928,936
| 11 Aug 2026 | 07:00:05 | Parsortix CTCs used for Brain Cancer detection |
| 3 Aug 2026 | 07:00:09 | Parsortix CTCs used for ADC target assessment |
| 16 Jul 2026 | 07:00:04 | Issue of Share Options |
| 15 Jul 2026 | 07:00:04 | Q2 and First Half Year Results ended 30 June 2026 |
| 14 Jul 2026 | 09:46:52 | Result of AGM |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
CelLBxHealth plc is a CTC intelligence company specializing in circulating tumour cell (CTC) solutions for research, drug development, and clinical oncology. Its Parsortix® platform harvests CTCs from blood and integrates with existing laboratory instruments for downstream analysis, including whole-cell imaging and genomic workflows. The company generates revenue through product sales of the Parsortix platform and consumables, laboratory services for clinical trials, and lab-developed tests pursued via partnerships and in-house development.
| 11 Aug 2026 | 07:00:05 | Parsortix CTCs used for Brain Cancer detection |
| 3 Aug 2026 | 07:00:09 | Parsortix CTCs used for ADC target assessment |
| 16 Jul 2026 | 07:00:04 | Issue of Share Options |
| 15 Jul 2026 | 07:00:04 | Q2 and First Half Year Results ended 30 June 2026 |
| 14 Jul 2026 | 09:46:52 | Result of AGM |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
CelLBxHealth plc is a CTC intelligence company specializing in circulating tumour cell (CTC) solutions for research, drug development, and clinical oncology. Its Parsortix® platform harvests CTCs from blood and integrates with existing laboratory instruments for downstream analysis, including whole-cell imaging and genomic workflows. The company generates revenue through product sales of the Parsortix platform and consumables, laboratory services for clinical trials, and lab-developed tests pursued via partnerships and in-house development.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £4.10bn | -0.1% | |
| £301m | -0.4% | |
| £296m | -0.1% | |
| £280m | -0.2% | |
| £22m | -0.7% | |
CLBXCellbxhealth PLC | — | -0.7% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £4.10bn | -0.1% | |
| £301m | -0.4% | |
| £296m | -0.1% | |
| £280m | -0.2% | |
| £22m | -0.7% | |
CLBXCellbxhealth PLC | — | -0.7% |
